| Product NDC: | 50222-403 |
| Proprietary Name: | Dovonex |
| Non Proprietary Name: | Calcipotriene |
| Active Ingredient(s): | .05 mg/mL & nbsp; Calcipotriene |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 50222-403 |
| Labeler Name: | LEO Pharma Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020611 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19970601 |
| Package NDC: | 50222-403-60 |
| Package Description: | 40 CARTON in 1 CASE (50222-403-60) > 1 BOTTLE in 1 CARTON > 60 mL in 1 BOTTLE |
| NDC Code | 50222-403-60 |
| Proprietary Name | Dovonex |
| Package Description | 40 CARTON in 1 CASE (50222-403-60) > 1 BOTTLE in 1 CARTON > 60 mL in 1 BOTTLE |
| Product NDC | 50222-403 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Calcipotriene |
| Dosage Form Name | SOLUTION |
| Route Name | TOPICAL |
| Start Marketing Date | 19970601 |
| Marketing Category Name | NDA |
| Labeler Name | LEO Pharma Inc. |
| Substance Name | CALCIPOTRIENE |
| Strength Number | .05 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Vitamin D [Chemical/Ingredient],Vitamin D Analog [EPC] |